ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

OCCURRENCE OF HOSPITAL ACQUIRED PNEUMONIA IN ICU AND IDENTIFICATION OF CAUSATIVE ORGANISMS

AUTHORS:

Dr Rabail Malhi, Dr Frieha Reza, Dr Jansa Waqas

ABSTRACT:

Abstract: Objective: The aim of this research work is to examine the prevalence of HAP (Hospital acquired Pneumonia) in the patients getting treatment in ICU (Intensive care unit) and to assess the occurrence of causative agents of this disease. Methodology: We carried out an observational study in intensive care unit of Jinnah Hospital, Lahore for the duration of one year, from January 2018 to January 2019. During this period 1,866 patients admitted in intensive care unit and medicine department. We analyzed these patients for HAP and cultured the disease-causing organisms from the patients. We carried out the microbiological etiology of these patients. Results: Total 346 patients got admission in intensive care unit. We identified Hospital acquired Pneumonia in eighty-eight patients. The patients suffering with this disease were from the age of sixteen to eighty-two years, having the average age of forty-eight years. There were fifty-six male patients and thirty-two female patients. The death of forty-two patients occurred due to this infection. Microbiological etiology indicated that there were 30.6% (27) Pseudomonas aeruginosa, 13.6% (12) Acinetobacter spp., 13.6% (12) Candida albicans, 10.2% (9) Klebsiella-pneumonia, 10.2% (9) Streptococcus spp., 5.6% (5) Escherichia coli, 4.5% (4) Stenotrophomonas spp., 4.5% (4) MRSA (Methicillin Resistant Staphylococcus Aureus) and 6.8% (6) other micro-organisms. Conclusion: The occurrence of hospital acquired pneumonia was 25.40% (88 out of 346 patients). The most common causative organism of HAP was Pseudomonas aeruginosa (30.60%). KEY WORDS: Escherichia Coli, Pneumonia, Pseudomonas Aeruginosa, Organisms, ICU, Infection, Specimen, Gram Stain.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.